ECP 2024 Final Programme

Tuesday, 10 Sept 230 LS-16 Industry Symposium 13:00–14:30 Spadolini 5 Illumina’s journey in precision pathology: from targeted panels to whole genome sequencing Illumina Chair: Giancarlo Pruneri, Italy 001 13:00–13:15 Empowering precision pathology: genomic tools Giancarlo Pruneri, Italy 002 13:15–13:35 Enhancing precision: leveraging small panels for oncology testing Giulia Cangi, Italy 003 13:35–13:55 Maximizing insights: comprehensive genomic profiling Sergio Villatoro, Spain 004 13:55–14:15 Charting the future of precision pathology: whole genome sequencing strategies Speaker to be confirmed 005 14:15–14:30 Unveiling the potential: panel discussion on the future of precision pathology All panellists LS-17 Industry Symposium 13:00–14:30 Spadolini 6 The future of pathology: liquid biopsy, novel biomarkers, and tumour-agnostic therapies Amgen Chair: Frédérique Penault-Llorca, France 001 13:00–13:05 Welcome and introduction Frédérique Penault-Llorca, France 002 13:05–13:30 Liquid biopsy in NSCLC: a discourse on controversies and advancements Lukas Bubendorf, Switzerland Fabio Pagni, Italy Industry Symposia 003 13:30–13:50 The next frontier: FGFR2b and CLDN18.2 as promising biomarkers for G/GEJ cancers Irene Esposito, Germany 004 13:50–14:10 Unlocking the power of MTAP-homozygous deletion: a tumour-agnostic biomarker Albrecht Stenzinger, Germany 005 14:10–14:25 Panel discussion and Q&A Frédérique Penault-Llorca, France 006 14:25–14:30 Summary and close Frédérique Penault-Llorca, France LS-18 Industry Symposium 13:00–14:30 Spadolini 7 How can scalable, open digital pathology solutions advance diagnostic quality and efficiency in pathology practice? Agilent Technologies Chairs: Jake Eden, Denmark Alan Byrne, Ireland 001 13:00-13:10 Welcome & Agilent Digital Pathology Focus Jake Eden, Denmark 002 13:10–13:25 From microscope to monitor: streamlining workflows with digital pathology Robert D. Goldin, United Kindom 003 13:25–13:40 Multi-site, multi-AI pathology: quality, efficiency, and lead-time impact through scaled algorithm deployment Teemu Tolonen, Finland 004 13:40–13:55 Integration of computational pathology algorithms in the clinical digital pathology workflow: connecting the dots Bert Van der Vegt, The Netherlands 005 13:55–14:10 Evolving role of digital pathology in anatomic and molecular pathology laboratories Holger Moch, Switzerland 006 14:10–14:30 Panel Discussion All panellists